Bluejay Therapeutics is a startup based in the United States, most recent round Acquired, 5 tracked investors.
Based in the United States, Bluejay Therapeutics is a startup. Bluejay Therapeutics has been acquired. Brouky records 5 investors associated with the company.
Bluejay Therapeutics is a clinical-stage biopharmaceutical company focused on developing potentially life-changing therapeutics for serious viral and liver diseases, primarily chronic hepatitis B and chronic hepatitis D.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.